TipRanks
Go Ultimate55% OFF

Oncopeptides AB (0RN4) Revenue

Oncopeptides AB Revenue

Oncopeptides AB had a revenue of 31.10M in the quarter ending Jun 30, 2026, with 22.51%. This bring the company's revenue in the last twelve months to 95.26M, Increased 14.30%. In the fiscal year ending Dec 31, 2025, Oncopeptides AB had annual revenue of 71.12M with 124.72% growth.

Revenue (ttm)
95.26M
Revenue Growth
87.23%
P/S Ratio
10.15
Revenue/Employee
SEK 1,030,696
Employees
69
Market Cap
SEK 721.66M

Revenue Chart

Oncopeptides AB Revenue - Annual

025M50M75M100M125M118.30M8.36M35.22M31.65M71.12M201720182019202020212022202320242025
Revenue History
Download to Excel
GB:0RN4 revenue history
Fiscal End DateRevenueChangeGrowth
Dec 31, 202571.12M39.47M124.72%
Dec 31, 202431.65M-3.57M-10.14%
Dec 31, 202335.22M26.86M321.54%
Dec 31, 20228.36M-109.94M-92.94%
Dec 31, 2021118.30M118.30M―
Dec 31, 20200.000.00―
Dec 31, 20190.000.00―
Dec 31, 20180.000.00―
Dec 31, 20170.00――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
GB:0RN495.26M
SE:ATORX283.00K
SE:BINV39.98M
SE:IMMU0.00
SE:CANTA317.31M
SE:SPRINT139.15M